The\u00a0COVID-19\u00a0pandemic will have a negative short-term effect on the global therapeutic\u00a0BTX\u00a0market. The deferral of nonurgent procedures, compounded with economic uncertainty across the globe will hinder procedure volumes and therefore impede market growth. Beyond the\u00a0COVID-19\u00a0pandemic, the global therapeutic\u00a0BTX\u00a0market will\u00a0grow strongly\u00a0through 2029, with newly approved indications, the need for repeat\u00a0BTX\u00a0treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales\u00a0expansion.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic\u00a0BTX\u00a0in the US, France, Germany, Italy, Spain, the UK, Japan and Australia across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-547712","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-therapeutic-botulinum-toxin","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/547712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/547712\/revisions"}],"predecessor-version":[{"id":547953,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/547712\/revisions\/547953"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=547712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}